Rapid Acting Insulin Market, Size, Share, Global Forecast 2024-2032
Renubresearch0129 Aug, 2024Health
The global rapid-acting insulin market is expected to grow at a CAGR of 4.75% and reach US$11. 17 billion by 2032, from US$7. 36 billion in 2023. The market is mainly driven by growth rate of diabetes and the rise in investment in research and development for human recombinant insulin. Rapid-acting insulin is a type of insulin designed to manage blood glucose levels quickly and efficiently. Unlike long-acting insulins, which are designed for sustained release throughout the day, rapid-acting insulins start to work within 15 minutes of injection, peak in about 1 to 2 hours, and last for 3 to 5 hours. This quick action mimics the natural insulin response to food intake, making it ideal for managing blood sugar spikes associated with meals.
Related Bookmarks
- Perfect point Everything You Need to Know About Hair Care and Treatment in Kanpur
- Boost Revenue with Expert Claim Submission & Denial Management: Essential Strategies for Healthcare
- Low Cost Spinal Fusion Surgery India
- Scope of a Gynae Pharma Franchise in India
- High-End Liver Disease Treatment in Delhi
- Increase Your Health with Foods High in Vitamin C: The Complete Guide
- 20-minute Cycling Workout
- Urokul Hospital | Best Urology Hospital in Pune
- Glutathione, often referred to as the �master antioxidant,� is a powerful substance your body
- Moringa Capsules, A Natural Solution for Inflammation and Blood Sugar Control
Recent Profiles
Emma Ava
Rr88
Skriver Warner
Key Beasley
Andrian Anderson
Timmons Drejer
Picturando
Mcintosh Hopper
Hjorth Carlsson
Shepard Gibbs